GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Caliber Imaging & Diagnostics Inc (OTCPK:LCDX) » Definitions » Forward PE Ratio

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Forward PE Ratio : 0.00 (As of Apr. 30, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Caliber Imaging & Diagnostics Forward PE Ratio?

Caliber Imaging & Diagnostics's Forward PE Ratio for today is 0.00.

Caliber Imaging & Diagnostics's PE Ratio without NRI for today is 0.00.

Caliber Imaging & Diagnostics's PE Ratio for today is 0.00.


Caliber Imaging & Diagnostics Forward PE Ratio Historical Data

The historical data trend for Caliber Imaging & Diagnostics's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliber Imaging & Diagnostics Forward PE Ratio Chart

Caliber Imaging & Diagnostics Annual Data
Trend
Forward PE Ratio

Caliber Imaging & Diagnostics Quarterly Data
Forward PE Ratio

Competitive Comparison of Caliber Imaging & Diagnostics's Forward PE Ratio

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliber Imaging & Diagnostics's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's Forward PE Ratio falls into.



Caliber Imaging & Diagnostics Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Caliber Imaging & Diagnostics  (OTCPK:LCDX) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Caliber Imaging & Diagnostics Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Caliber Imaging & Diagnostics's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
100 Burtt Road, Suite 203, Andover, MA, USA, 01810
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.
Executives
Paul Stuka director C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
William J Shea director, 10 percent owner 11825 N PENNSYLVANIA ST, CARMEL IN 46032
Kevin M Cronin director
Richard Christopher officer: Chief Financial Officer C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
Martin Joseph Joyce officer: Chief Financial Officer 1050 HINGHAM STREET, ROCKLAND MA 02370
Matthew S Cox director 58 OAKWOOD DRIVE, CHAPEL HILL NC 27517

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Headlines